One component of GEC, the Medullary Thyroid Cancer (MTC) Classifier, has been far less studied (Table 4). Among the few existing studies, Se, Sp, PPV, and NPV ranged from 91 to 100%, 100%, 98 to 100%, and 99 to 100%, respectively. Further evaluation of the MTC Classifier is needed to establish its clinical efficacy.